Nureca Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/01/2026 ,inter alia, to consider and approve Declaration of Financial Results and ....
NURECA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nureca Ltd has informed the stock exchanges that its Board of Directors will meet on January 17, 2026 to consider and approve the unaudited standalone and consolidated financial results for the third quarter and nine months ended December 31, 2025. The filing is made under SEBI Listing Regulations (29 and 30) and is a routine compliance disclosure ahead of the earnings announcement. No financial figures, estimates, or guidance have been disclosed in this notice. The signatory is the Company Secretary, Nishu Kansal.
This is a routine pre-earnings intimation and does not itself move the stock. Investors should watch the actual Q3 FY26 results expected after January 17, 2026 for revenue, margin, and profit trends.